Indianapolis Gastroenterology Research Foundation
Indianapolis, Indiana, United States
Gastroenterologist in Indianapolis, Indiana
8051 Emerson Ave, Indianapolis, IN 46237
About Indianapolis Gastroenterology Research Foundation
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Gilead Sciences
16
Target PharmaSolutions, Inc.
2
Abbott
1
Bausch Health Americas, Inc.
1
Biogen
1
CymaBay Therapeutics, Inc.
1
Exact Sciences Corporation
1
Medtronic - MITG
1
Takeda
1
Tioga Pharmaceuticals
1
Tobira Therapeutics, Inc.
1
Clinical Trials at Indianapolis Gastroenterology Research Foundation
During the past decade, Indianapolis Gastroenterology Research Foundation conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 10 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 7 clinical trials were completed. i.e. 700%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Adalimumab for the Induction and Maintenance of Clinical Remission in Subjects With Crohn's Disease
2003-07-01
Completed
854
A Clinical Trial of Natalizumab in Individuals With Moderately to Severely Active Crohn's Disease
2004-03-01
2005-03-01
Completed
462
Study to Assess the Efficacy and Safety of Rifaximin Administered BID in the Treatment of Patients With Diarrhea-Associated Irritable Bowel Syndrome
2005-12-01
2008-09-01
Completed
525
Asimadoline for the Treatment of Subjects With Irritable Bowel Syndrome
2006-08-01
2007-12-01
Completed
596
Oral Antivirals (GS-5885, Tegobuvir, and/or GS-9451) With Peginterferon Alfa 2a and Ribavirin in Treatment Experienced Subjects With Chronic Genotype 1 Hepatitis C Virus Infection
2011-07-01
2013-03-01
Completed
163
GS-5885, GS-9451 With Peginterferon Alfa 2a (PEG) and Ribavirin in Treatment-Naïve Subjects With Chronic Genotype 1 Hep C Virus Infection and IL28B CC Genotype
2011-08-01
2013-06-01
Terminated
248
GS-5885, GS-9451, Tegobuvir and Ribavirin (RBV) in Interferon Ineligible or Intolerant Subjects With Chronic Genotype 1a or 1b Hepatitis C Virus (HCV) Infection
2011-09-01
2013-01-01
Completed
163
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Indianapolis Gastroenterology Research Foundation" #1 sponsor was "Gilead Sciences" with 16 trials, followed by "Target PharmaSolutions, Inc." with 2 trials
sponsored, "Abbott" with 1 trials sponsored, "Bausch Health Americas, Inc." with 1 trials sponsored and "Biogen"
with 1 trials sponsored. Other sponsors include 1 different institutions and
companies that sponsored additional 11 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Indianapolis Gastroenterology Research Foundation"
#1 collaborator was "COUR Pharmaceuticals Development Company, Inc." with 1 trials as a collaborator, "Elan Pharmaceuticals" with 1 trials as a collaborator and "RTI Health Solutions" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Indianapolis Gastroenterology Research Foundation
According to Clinical.Site data, the most researched conditions in "Indianapolis Gastroenterology Research Foundation" are
"Chronic Hepatitis C" (5 trials), "Nonalcoholic Steatohepatitis" (5 trials), "Crohn's Disease" (3 trials), "Hepatitis C, Chronic" (3 trials) and "Irritable Bowel Syndrome" (2 trials). Many other conditions were trialed in "Indianapolis Gastroenterology Research Foundation" in a lesser frequency.
Clinical Trials Intervention Types at Indianapolis Gastroenterology Research Foundation
Most popular intervention types in "Indianapolis Gastroenterology Research Foundation" are "Drug" (19 trials), "Biological" (3 trials), "Device" (3 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (6 trials), "RBV" (6 trials), "PEG" (3 trials), "SEL" (3 trials) and "SOF" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Indianapolis Gastroenterology Research Foundation
The vast majority of trials in "Indianapolis Gastroenterology Research Foundation" are
27 trials for "All" genders.
Clinical Trials Status at Indianapolis Gastroenterology Research Foundation
Currently, there are NaN active trials in "Indianapolis Gastroenterology Research Foundation".
undefined are not yet recruiting,
2 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 19 completed trials in Indianapolis Gastroenterology Research Foundation,
undefined suspended trials,
and 5 terminated clinical trials to date.
Out of the total trials that were conducted in Indianapolis Gastroenterology Research Foundation, 0 "Phase 1"
clinical trials were conducted, 9 "Phase 2" clinical
trials and 11 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".